Find News

Filter articles

Applied Filters

Showing 41 to 50 of 957 results

Kilpatrick Townsend hires litigation team from DLA Piper

US19-10-2020Sarah Morgan

Kilpatrick Townsend & Stockton has strengthened its life sciences expertise with the addition of a patent litigation team, that includes four litigators from DLA Piper.

Seventh Circuit urged to review AbbVie antitrust ruling

US15-10-2020Muireann Bolger

Twenty US states, the US Federal Trade Commission, and consumer groups have asked the Seventh Circuit of the US Court of Appeals to reconsider a case claiming that AbbVie strived to prevent competition to its immunosuppressant drug, Humira.

Novartis MS drug appeal upheld in Australia

Australia13-10-2020Sarah Morgan

The Federal Court of Australia has backed Novartis’ appeal against a decision revoking its patent covering a multiple sclerosis drug.

Fed Circuit reinstates $235m verdict against Teva

US06-10-2020Sarah Morgan

In a victory for GlaxoSmithKline, the US Court of Appeals for the Federal Circuit has revived a 2017 jury verdict ordering Teva to pay $235 million over the drug Coreg.

Celgene, Teva execs grilled over price hikes

US01-10-2020Rory O'Neill

A US House of Representatives committee has accused Teva and Celgene of imposing unjustified price hikes on blockbuster drugs Copaxone and Revlimid.

Collegium settles patent dispute with Teva

Israel, US30-09-2020Sarah Morgan

Massachusetts-based Collegium Pharmaceutical has reached a settlement agreement with Teva, resolving its patent litigation over pain medication.

Janssen sues Mylan to block generic of schizophrenia drug

US29-09-2020Muireann Bolger

A Johnson & Johnson company, Janssen Pharmaceuticals, is seeking a court order blocking Mylan from making copies of its schizophrenia treatment, Invega Trinza, until its patent expires in 2036.

Bausch Health settles with Sun Pharma

Canada, India, US23-09-2020Sarah Morgan

Canada-based Bausch Health has dropped its litigation against Indian generic maker Sun Pharma as part of a settlement agreement.

BMS and Dr Reddy’s settle Revlimid suit with generics licence

US22-09-2020Rory O'Neill

Bristol Myers Squibb and Celgene have settled their patent litigation with Dr Reddy’s over a generic version of cancer drug Revlimid.

Gilead accused of illegally paying to delay HIV drug competition

US22-09-2020Muireann Bolger

Biopharmaceutical company Gilead is being sued for allegedly scheming to prevent a generic rival from releasing a competing version of its HIV drug Truvada, according to a class action lawsuit filed by investors in the drug manufacturer.

Showing 41 to 50 of 957 results